SCAPER expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.18020046460765E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.74780000028463E-07 |
Normal-vs-Stage2 |
1.59949999911646E-08 |
Normal-vs-Stage3 |
6.39829999982133E-07 |
Normal-vs-Stage4 |
2.40859999722787E-08 |
Stage1-vs-Stage2 |
1.001240E-01 |
Stage1-vs-Stage3 |
1.562190E-01 |
Stage1-vs-Stage4 |
3.622000E-02 |
Stage2-vs-Stage3 |
8.983400E-01 |
Stage2-vs-Stage4 |
5.284800E-01 |
Stage3-vs-Stage4 |
5.233400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.16910001071824E-09 |
Normal-vs-AfricanAmerican |
3.361500000576E-08 |
Normal-vs-Asian |
1.212600E-04 |
Caucasian-vs-AfricanAmerican |
7.639200E-01 |
Caucasian-vs-Asian |
6.920200E-01 |
AfricanAmerican-vs-Asian |
6.656400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.04799502409492E-11 |
Normal-vs-Female |
2.575700E-03 |
Male-vs-Female |
4.444500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.640400E-03 |
Normal-vs-Extreme_Weight |
2.56660004360754E-09 |
Normal-vs-Obese |
2.48219999998689E-06 |
Normal-vs-Extreme_Obese |
1.225520E-02 |
Normal_Weight-vs-Extreme_Weight |
4.437800E-01 |
Normal_Weight-vs-Obese |
9.616600E-01 |
Normal_Weight-vs-Extreme_Obese |
8.890800E-01 |
Extreme_Weight-vs-Obese |
2.400400E-01 |
Extreme_Weight-vs-Extreme_Obese |
7.146800E-01 |
Obese-vs-Extreme_Obese |
8.069600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.119100E-03 |
Normal-vs-Age(41-60Yrs) |
1.65460000001172E-06 |
Normal-vs-Age(61-80Yrs) |
2.99959945770922E-10 |
Normal-vs-Age(81-100Yrs) |
3.74610000020148E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.776600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.170800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.436200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.891800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.169040E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.665400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
9.08980000158266E-08 |
Normal-VS-Type2 PRCC |
1.02700004056544E-09 |
Normal-VS-KIRP CIMP |
2.579400E-03 |
Normal-VS-Unclassified PRCC |
2.36399999999914E-05 |
Type1 PRCC-VS-Type2 PRCC |
1.058970E-01 |
Type1 PRCC-VS-KIRP CIMP |
3.828400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
6.360400E-01 |
Type2 PRCC-VS-KIRP CIMP |
7.712800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
4.805200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
4.687400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.86528570367273E-12 |
Normal-vs-N1 |
2.41970000036673E-07 |
Normal-vs-N2 |
1.75896999999869E-05 |
N0-vs-N1 |
4.045600E-01 |
N0-vs-N2 |
4.458200E-01 |
N1-vs-N2 |
3.175400E-01 |
|
|